News from d-pharm ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

21 Nov, 2013, 09:14 GMT D-Pharm starts Phase 2 Clinical Study with DP-b99 in Acute High-Risk Pancreatitis Patients

D-Pharm Ltd (TASE:DPRM) announced today November 21st 2013, receipt of approval from the regulatory authorities in Slovakia to commence a Phase 2...


30 Oct, 2013, 08:00 GMT D-Pharm Granted Patent in US and China for its Phase II Product THR-18

D-Pharm Ltd (TASE: DPRM) announced today, October 30 2013, that a new patent has been granted in the US and China related to composition and use of...


16 Oct, 2013, 08:00 BST D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator (tPA)

D-Pharm Ltd (TASE: DPRM) announced today, October 16th 2013, receipt of approval from the regulatory authorities in the Ukraine to commence a Phase...


14 Oct, 2013, 09:00 BST D-Pharm Schedules Investigators Meeting to Discuss Protocol of Phase 2 Clinical Study of DP-b99 for Acute High-Risk Pancreatitis

D-Pharm Ltd (TASE: DPRM) announced today October 14th 2013, that an Investigators Meeting has been scheduled later this month, in Prague, to discuss...


19 Aug, 2013, 09:00 BST Positive Results for D-Pharm's Investigational Drugs in Models of Human African Trypanosomiasis and Malaria

 D-Pharm Ltd., (TASE: DPRM) announced today on-line publication of promising results with its drug candidates, DP-460 and DP-b99, in models of human ...


31 Oct, 2011, 16:47 GMT D-Pharm Announces Expected Date of Interim Report for the DP-b99 Acute Ischemic Stroke Study, MACSI

D-Pharm Ltd., (TASE: DPRM) announced today that the interim report for the DP-b99 MACSI study is expected in February, 2012. The report will be based ...


24 Aug, 2011, 13:00 BST KFDA Grants IND Approval for Phase III MACSI Study of DP-b99 in Korea

? D-Pharm Ltd., (TASE: DPRM) announced today that the Korean Food & Drug Administration (KFDA) approved the Investigational New Drug (IND)...


20 Jul, 2011, 15:02 BST D-Pharm Receives Nod From DSMB to Continue the DP-b99 MACSI Phase III Study in Stroke Patients

D-Pharm Ltd., (TASE: DPRM) announced today that the Data and Safety Monitoring Board (DSMB) for the Membrane Activated Chelator Stroke Intervention...


14 Jun, 2011, 13:00 BST DP-b99 Phase III MACSI Study Protocol Published in International Journal of Stroke

D-Pharm Ltd., (TASE: DPRM) announced today publication, on-line, in the International Journal of Stroke the protocol for its ongoing, Phase III,...


31 May, 2011, 13:00 BST D-Pharm Signs Deal With Jiangsu NHWA Pharmaceutical for Development and Commercialization of DP-VPA in China

D-Pharm Ltd. (TASE: DPRM) announced today that it has entered into a licensing and co-development agreement with Jiangsu NHWA Pharmaceutical Co., Ltd....